Gene and protein expression profiles associated with the therapeutic efficacy of irinotecan
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 12, 2013
Grant Date -
Dec 3, 2009
app pub date -
Jun 18, 2009
filing date -
Sep 21, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention includes gene and protein expression profiles indicative of whether a cancer patient is likely to respond to treatment with irinotecan. By identifying such responsiveness, a treatment provider may determine in advance those patients who would benefit from such treatment, as well as identify alternative therapies for non-responders. The present invention further provide methods of using the gene and/or protein expression profiles and assays for identifying the presence of a gene and/or protein expression profile in a patient sample.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully